Nigella 5 in the Treatment of SARS COV2 (COVID-19)

Clinical trial NCT04914767 · COMPLETED

Trial details

NCT number: NCT04914767
Sponsor: Hôpital Universitaire Sahloul
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

SARS-CoV2 Infection

Start date: 2021-03-01
Primary completion: 2021-10-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.